跳至主要内容
临床试验/CTRI/2021/06/034382
CTRI/2021/06/034382招募中2 期

Corneal Dystrophies Caused by SLC4A11 Mutation: A Promising NewParadigm Shift in Therapy Using an Ophthalmic Nonsteroidal Anti-InflammatoryEye Drops

Hyderabad Eye Research Foundation0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Children upto 9 years of age diagnosed with CHED (Congenital Hereditary Endothelial Dystrophy) with bilaterally equal corneal involvement
  • -Patients agreeing on a regular monthly follow-up for a minimum of 6 months

排除标准

  • 1. Patients undergone eye surgery (PK,DSEK,DMEK, Glaucoma surgery, etc)
  • 2. Patient with eye pathologies like-glaucoma,dry eye,nystagmus,cataract,corneal ulcer,reduced corneal sensations,etc
  • 3. Not able to come for follow up
  • 4.Asymmetrical corneal involvement
  • 5.Allergy to the drug
  • 6. Patients with asthma or bleeding dyscrasias
  • 7. Non-cooperative children

研究者

相似试验